AP Biology 4.6 Regulation of Cell Cycle Questions
Practise AP Biology 4.6 questions by connecting checkpoints and tumor suppressors with controlled division, DNA-damage responses and cancer.
- Syllabus
- Effective Fall 2025
- Course
- AP Biology
Practise AP Biology 4.6 questions by connecting checkpoints and tumor suppressors with controlled division, DNA-damage responses and cancer.
The p53 protein is a transcription factor that regulates a cell's progression through the cell cycle after DNA is damaged by ultraviolet (UV) radiation. The p53 pathway is shown in Figure 1.
Figure 1. The role of p53 in regulating cell cycle progression in response to DNA damage
Based on Figure 1, explain how p53 regulates the cell cycle in the presence of damaged DNA.
- p53 stimulates expression of the CDK inhibitor, preventing progression of the
cell cycle. (The CDK inhibitor blocks the interaction between the CDK and
cyclins.)
Based on Figure 1, explain how a mutation to p53 may lead to an increased risk of cancer.
A mutation may prevent activation of p53, which will then not stimulate the CDK inhibitor, allowing the cell cycle to progress through the cell cycle with damaged or mutated DNA.
The p53 protein is a transcription factor that regulates a cell's progression through the cell cycle after DNA is damaged by ultraviolet (UV) radiation. The p53 pathway is shown in Figure 1.
Figure 1. The role of p53 in regulating cell cycle progression in response to DNA damage
Based on Figure 1, explain how p53 regulates the cell cycle in the presence of damaged DNA.
- p53 stimulates expression of the CDK inhibitor, preventing progression of the
cell cycle. (The CDK inhibitor blocks the interaction between the CDK and
cyclins.)
The p53 protein is a transcription factor that regulates a cell's progression through the cell cycle after DNA is damaged by ultraviolet (UV) radiation. The p53 pathway is shown in Figure 1.
Figure 1. The role of p53 in regulating cell cycle progression in response to DNA damage
Based on Figure 1, explain how a mutation to p53 may lead to an increased risk of cancer.
A mutation may prevent activation of p53, which will then not stimulate the CDK inhibitor, allowing the cell cycle to progress through the cell cycle with damaged or mutated DNA.